AGF Investments Inc’s Edwards Lifesciences EW Stock Holding History

AGF Investments Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,234	Closed	-$751K	–	749
2020 Q4	$751K	Buy	+8,234	New	+$683K	0.01%	426
2017 Q4	–	Sell	-954,831	Closed	-$34.8M	–	382
2017 Q3	$34.8M	Sell	954,831 -47,883	-5%	-$1.83M	0.38%	83
2017 Q2	$39.5M	Buy	1,002,714 +3,609	+0.4%	+$132K	0.45%	76
2017 Q1	$31.3M	Sell	999,105 -800,577	-44%	-$25.1M	0.34%	94
2016 Q4	$56.2M	Sell	1,799,682 -96,495	-5%	-$3.13M	0.65%	55
2016 Q3	$76.2M	Sell	1,896,177 -56,838	-3%	-$2.14M	0.85%	32
2016 Q2	$64.9M	Buy	1,953,015 +722,190	+59%	+$24.7M	0.72%	42
2016 Q1	$36.2M	Buy	1,230,825 +60,243	+5%	+$1.66M	0.44%	82
2015 Q4	$30.8M	Buy	+1,170,582	New	+$30.4M	0.38%	89
2014 Q2	–	Sell	-600	Closed	-$7K	–	399
2014 Q1	$7K	Buy	+600	New	+$6.92K	﹤0.01%	404

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AGF Investments Inc's EW Position: Q1 2021 in Review

AGF Investments Inc sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 8,234 shares — an estimated $751K sold.

AGF Investments Inc first reported a position in EW in Q1 2014 and held it in 10 quarters. The position peaked at $76.2M in Q3 2016. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.

AGF Investments Inc reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
AGF Investments Inc sold 8,234 Edwards Lifesciences shares in Q1 2021, an estimated $751K.
AGF Investments Inc first reported a position in Edwards Lifesciences in Q1 2014 and held it in 10 quarters.
AGF Investments Inc's Edwards Lifesciences position peaked at $76.2M in Q3 2016.
1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on AGF Investments Inc's 13F filing for Q1 2021, filed 14 May 2021.